The CEO of Eshmoun-Clinical Research, Dr Souad Dziri, was the guest speaker at the first International Congress of the Tunisian Society of Pharmacy and Oncology to discuss the role of CROs in setting up clinical trials during the second session of the day on the theme of Clinical Research in Oncology.
